
     RDKit          3D

 10 10  0  0  1  0  0  0  0  0999 V2000
    1.0244   -0.0413   -0.0641 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7185   -3.1185    1.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3674   -1.4184    0.0324 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.1153   -1.7199    1.4672 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.2503   -4.1562    0.9923 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.6907   -3.7492   -0.4342 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.9298   -1.5758    2.4294 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3513   -5.4478    1.0708 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3674   -3.8719   -1.3782 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2582   -2.4354   -0.4555 O   0  0  0  0  0  0  0  0  0  0  0  0
  3  1  1  1
  4  2  1  0
  4  3  1  0
  4  7  1  1
  5  2  1  0
  5  8  1  6
  6  5  1  0
  6  9  1  6
 10  3  1  0
 10  6  1  0
M  END
>  <DRUGBANK_ID>  (1) 
DB02590

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT00394

>  <COMMON_NAME>  (1) 
Abequose

>  <CAS_NUMBER>  (1) 
56816-60-5

>  <UNII>  (1) 
2PVB5DNX65

>  <SYNONYMS>  (1) 
3,6-dideoxy-α-D-xylo-hexopyranose; alpha-abequopyranose; α-abequopyranose

$$$$
